Haemonetics Corp
HAE· NYSE
HAEHaemonetics Corp
Filed Feb 6, 2012 · 10-Q · 37 days after period end · 0000313143-12-000014
| Metric | Q3 2011 | Q3 2010 | Q3 2009 |
|---|---|---|---|
| Revenue | $191.16M | $176.79M | $165.17M |
| Net Income | $18.25M | $19.73M | $18.29M |
| EPS Diluted | $0.36 | $0.77 | $0.71 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Haemonetics Corp · CIK 313143 · Engraved from SEC EDGAR
ended Dec 31, 2011 · filed Feb 6, 2012 · 37 d after period end
